10, 2024 — A newer vaccine against hepatitis B virus was clearly superior to an older vaccine type in inducing a protective antibody response among people living with HIV who didn't respond to prior ...

The "Human Immunodeficiency Virus (HIV): Epidemiology Forecast to 2033" report has been added to ResearchAndMarkets.com's offering. This report provides an overview of the risk factors, comorbidities, ...

HIV infection leads to a phenomenon of inflammaging, in which chronic inflammation induces an immune aged phenotype, even in individuals on combined antiretroviral therapy (cART) with undetectable ...

Curing HIV will be harder than curing cancer. Apart from a few 'miracle' cases, antiretrovirals only suppress HIV, they don't kill it. But new research is promising.

SORSOGON CITY, Sorsogon (PIA) — The Department of Health – Bicol Center for Health Development (DOH-CHD) urges vulnerable ...

Pseudoscience has recently re-emerged in the U.S. While much of it concerns vaccines, an "oldie" is again making the rounds: ...

PEPFAR has saved 25 million lives around the globe and is considered George W. Bush's greatest achievement. Donald Trump has left its future in doubt.

Staying Golden: Aging With HIV: The Way Forward A longtime HIV/AIDS researcher and clinician maps out potential ways to approach a curative strategy, and comments on the need for global resources ...

What you need to know ### BMJ Learning To obtain accredited continuous professional development points, subscribers to BMJ Learning can complete the full module at The module contains seven ...

Highly active antiretroviral therapy (HAART) limits HIV-1 replication and retards disease progression, but drug toxicities and emergence of drug-resistant viruses are challenges for long-term ...

Gilead Sciences, Inc. (NASDAQ:GILD), a leading biopharmaceutical company with a market capitalization of $119.32 billion, has been making significant strides in its core HIV franchise while expanding ...